Skip to content

Released Oct 29, 2018, after the close

10-Q filed Oct 29, 2018, 29 days after period end · 0001564590-18-025415

Q3 2018 · 10-Q
Revenue$111.71M+6.1% vs Q3 2017+0.1% vs Q2 2018
Net Income-$1.21MN/M vs Q3 2017N/M vs Q2 2018
EPS Diluted-$0.07N/M vs Q3 2017N/M vs Q2 2018
Gross Profit$87,688,000+7.6%
Operating Income$3,907,000−56.8%
Operating Cash Flowderived$15,797,000+14.7%
Free Cash Flowderived$11,993,000+28.1%
Margins · derived
Gross margin78.5%+1.0 pt vs Q3 2017
Operating margin3.5%−5.1 pt vs Q3 2017
Net margin-1.1%−4.4 pt vs Q3 2017

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2018Q3 2017Q3 2016Q3 2015
Revenue$111.71M$105.25M$98.50M$101.15M
Net Income-$1.21M$3.46M$9.90M-$1.37M
EPS Diluted-$0.07$0.19$0.54-$0.07

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR